{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:09:18Z","timestamp":1747195758275,"version":"3.40.5"},"reference-count":0,"publisher":"Nofer Institute of Occupational Medicine","issue":"3","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/pl\/deed.en"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Pr"],"published-print":{"date-parts":[[2020,5,15]]},"DOI":"10.13075\/mp.5893.00977","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T04:16:43Z","timestamp":1587442603000},"page":"363-373","source":"Crossref","is-referenced-by-count":0,"title":["Fluorouracil and doxorubicin \u2013 cardiotoxic cytostatics in the workplace"],"prefix":"10.13075","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9633-9428","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Kupczewska-Dobecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-6861","authenticated-orcid":false,"given":"S\u0142awomir","family":"Czerczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5258","container-title":["Medycyna Pracy"],"original-title":["Fluorouracyl i doksorubicyna \u2013 kardiotoksyczne cytostatyki w miejscu pracy"],"link":[{"URL":"http:\/\/www.journalssystem.com\/medpr\/pdf-118610-50794?filename=Med_Pr_2020_vol_71_issue_3_Kupczewska-Dobecka.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T08:03:59Z","timestamp":1590653039000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.journalssystem.com\/medpr\/FLUOROURACYL-I-DOKSORUBICYNA-KARDIOTOKSYCZNE-CYTOSTATYKI-W-MIEJSCU-PRACY-,118610,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["118610"],"URL":"https:\/\/doi.org\/10.13075\/mp.5893.00977","relation":{},"ISSN":["0465-5893","2353-1339"],"issn-type":[{"type":"print","value":"0465-5893"},{"type":"electronic","value":"2353-1339"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}